Farther Finance Advisors LLC decreased its stake in shares of Aflac Incorporated (NYSE:AFL – Free Report) by 33.7% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 9,135 shares of the financial services provider’s stock after selling 4,636 shares during the quarter. Farther Finance Advisors LLC’s holdings in Aflac were worth $945,000 at the end of the most recent quarter.
Other institutional investors have also recently made changes to their positions in the company. Private Trust Co. NA raised its stake in Aflac by 1.3% in the 4th quarter. Private Trust Co. NA now owns 7,643 shares of the financial services provider’s stock valued at $791,000 after acquiring an additional 99 shares during the period. Phillips Wealth Planners LLC raised its stake in Aflac by 1.5% in the 4th quarter. Phillips Wealth Planners LLC now owns 6,553 shares of the financial services provider’s stock valued at $662,000 after acquiring an additional 100 shares during the period. Raleigh Capital Management Inc. raised its stake in Aflac by 23.2% in the 4th quarter. Raleigh Capital Management Inc. now owns 531 shares of the financial services provider’s stock valued at $55,000 after acquiring an additional 100 shares during the period. TKG Advisors LLC raised its stake in Aflac by 0.5% in the 4th quarter. TKG Advisors LLC now owns 21,255 shares of the financial services provider’s stock valued at $2,230,000 after acquiring an additional 103 shares during the period. Finally, Covestor Ltd raised its stake in Aflac by 41.8% in the 3rd quarter. Covestor Ltd now owns 363 shares of the financial services provider’s stock valued at $41,000 after acquiring an additional 107 shares during the period. Institutional investors and hedge funds own 67.44% of the company’s stock.
Aflac Stock Performance
AFL opened at $107.44 on Friday. The firm has a market cap of $58.72 billion, a P/E ratio of 11.19, a price-to-earnings-growth ratio of 3.24 and a beta of 0.93. Aflac Incorporated has a 52-week low of $79.31 and a 52-week high of $115.50. The company has a debt-to-equity ratio of 0.29, a quick ratio of 0.08 and a current ratio of 0.10. The business’s fifty day moving average is $105.37 and its 200-day moving average is $107.69.
Wall Street Analysts Forecast Growth
A number of equities research analysts recently weighed in on the company. JPMorgan Chase & Co. increased their price target on Aflac from $90.00 to $94.00 and gave the company a “neutral” rating in a research note on Tuesday, January 7th. Barclays dropped their price target on Aflac from $98.00 to $95.00 and set an “underweight” rating on the stock in a research note on Friday, February 7th. Piper Sandler lowered their price objective on Aflac from $122.00 to $118.00 and set an “overweight” rating on the stock in a research report on Friday, February 7th. Wells Fargo & Company lowered their price objective on Aflac from $104.00 to $102.00 and set an “equal weight” rating on the stock in a research report on Wednesday, February 19th. Finally, Morgan Stanley increased their price objective on Aflac from $98.00 to $105.00 and gave the stock an “equal weight” rating in a research report on Friday, February 28th. Two research analysts have rated the stock with a sell rating, eleven have issued a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat.com, Aflac has an average rating of “Hold” and a consensus price target of $103.36.
Read Our Latest Analysis on AFL
Insider Activity at Aflac
In related news, Director Joseph L. Moskowitz sold 1,000 shares of the firm’s stock in a transaction dated Friday, March 7th. The stock was sold at an average price of $107.63, for a total value of $107,630.00. Following the sale, the director now directly owns 25,393 shares of the company’s stock, valued at $2,733,048.59. This trade represents a 3.79 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, Director Charles D. Lake II sold 29,802 shares of the stock in a transaction dated Monday, March 10th. The shares were sold at an average price of $107.29, for a total value of $3,197,456.58. Following the completion of the transaction, the director now owns 49,962 shares of the company’s stock, valued at $5,360,422.98. This represents a 37.36 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 55,546 shares of company stock valued at $5,863,616 over the last ninety days. 0.90% of the stock is owned by corporate insiders.
Aflac Company Profile
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.
Featured Articles
- Five stocks we like better than Aflac
- What Does Downgrade Mean in Investing?
- Rubrik Stock’s V-Bottom Reversal Signals a Major Rally Ahead
- How to Use the MarketBeat Stock Screener
- How Super Micro Computer Stock Is Defying the Market Sell-Off
- Growth Stocks: What They Are, Examples and How to Invest
- AppLovin vs. HPE: Which Tech Stock Can Bounce Back Faster?
Want to see what other hedge funds are holding AFL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aflac Incorporated (NYSE:AFL – Free Report).
Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.